KRAS and neoplasm: While we have previously demonstrated detection of early‐stage PDAC using exocrine pancreas methylation markers in cfDNA,3 here we show that methylation markers, when combined with circulating tumour KRAS mutation detection and imaging measurements, can predict the presence of occult metastatic disease before curative intent surgery.